Suppression of 7,12-dimethylbenz[α]anthracene-induced carcinogenesis and hypercholesterolaemia in rats by tocotrienol-rich fraction isolated from rice bran oil

European Journal of Cancer Prevention

Volumn 12, Issue 6, 2003, Pages 447-453

  Iqbal, J ^a   Minhajuddin, M ^b   Beg, Z H ^c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

12 dimethylbenz anthracene; 3 hydroxy 3 methylglutaryl coenzyme A reductase; 7; Carcinogenesis; Hypercholesterolaemia; Tocopherols; Tocotrienol rich fraction; Tocotrienols

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ACYL COENZYME A; ALKALINE PHOSPHATASE; ALPHA TOCOTRIENOL; ANTIOXIDANT; CARCINOGEN; CHOLESTEROL; GLUTATHIONE TRANSFERASE; RICE BRAN OIL; VEGETABLE OIL;

ANIMAL; ARTICLE; CELL TRANSFORMATION; CHEMISTRY; EXPERIMENTAL NEOPLASM; FEMALE; HYPERCHOLESTEROLEMIA; LIVER; ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ACYL COENZYME A; ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; ANIMALS; ANTIOXIDANTS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CHOLESTEROL; FEMALE; GLUTATHIONE TRANSFERASE; HYPERCHOLESTEROLEMIA; LIVER; MAMMARY NEOPLASMS, ANIMAL; PLANT OILS; RATS; RATS, SPRAGUE-DAWLEY; TOCOTRIENOLS;

EID: 2442477700     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/00008469-200312000-00002     Document Type: Article

References (60)

1. Albert RE, Vanderlaan M, Burns FJ, et al. 1977. Effect of carcinogens on chicken atherosclerosis. Cancer Res 37: 2232-2235.
2. Annino JS, Giese RW 1976. Clinical Chemistry. Principles and Procedures, 4th edn. Little, Brown and Company, Boston, pp. 268.
3. Bachorik PS, Albers JJ 1986. Precipitation methods for quantification of lipoproteins. Methods Enzymol 129: 78-100.
4. Bond JA, Gown AM, Yang HL, et al. 1981. Further investigation of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. J Toxicol Environ Health 7: 327-335.
5. Bradford MM 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72: 248-254.
6. Budin JT, Breene WM, Putnam DH 1995. Some compositional properties of Camelina (Camelina sativa L. Crantz) seeds and oils. J Am Oil Chem Soc 72: 309-315.
7. Chao JT, Gapor A, Theriault A 2002. Inhibitory effect of delta-tocotrienol, a HMG CoA reductase inhibitor, on monocyte-endothelial cell adhesion. J Nutr Sci Vitaminol 48: 332-337.
8. Clegg RJ, Middleton B, Bell GD, et al. 1982. The mechanism of cyclic monoterpene inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase in vivo in the rat. J Biol Chem 257: 2294-2299.
9. Duckworth PF, Vlahcevic ZR, Studer EJ, et al. 1991. Effect of hydrophobic bile acids on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and mRNA levels in rat. J Biol Chem 266: 9413-9418.
10. Eaton DL, Bammler TK 1999. Concise review of the glutathione S-transferase and their significance to toxicology. Toxicol Sci 49: 156-164.
11. Edwards PA, Gould RG 1972. Turnover rate of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase as determined by use of cycloheximide. J Biol Chem 247: 1520-1524.
12. Edwards PA, Popjak G, Fogelman AM, et al. 1997. Control of 3-hydroxy-3-methylglutaryl coenzyme A reductase by endogenously synthesized sterols in vitro and in vivo. J Biol Chem 252: 1057-1063.
13. Elson CE, Qureshi AA 1995. Coupling the cholesterol- and tumour-suppressive actions of palm oil to the impact of its minor constituents on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Prostaglandins Leukot Essent Fatty Acids 52: 205-208.
14. Elson CE, Maltzman TH, Boston JL, et al. 1988. Anticarcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis. Carcinogenesis 9: 331-332.
15. Engstrom W, Schofield PM 1987. Expression of the 3-hydroxy-3-methylglutaryl coenzyme A reductase and LDL-receptor and LDL-receptor genes in human embryonic tumours and in normal foetal tissues. Anticancer Res 7: 337-342.
16. Gould MN, Haag JD, Kennan WS, et al. 1991. A comparison of tocopherol and tocotrienol for the chemoprevention of chemically induced rat mammary tumours. Am J Clin Nutr 53: 1068S-1070S.
17. Guthrie N, Chambers AF, Gapor A, et al. 1997. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen alone and in combination. J Nutr 127: 544S-548S.
18. Habig WH, Pabst MJ, Jakoby WB 1974. Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139.
19. Hendrich S, Pitot HC 1987. Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis. Cancer Metastasis Rev 6: 155-178.
20. Herzfeld A, Greengard O 1977. The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat. Cancer Res 37: 231-238.
21. Jakoby WB, Habig WH 1980. Glutathione transferase. In: Jakoby WB, (ed.). Enzymatic Basis of Detoxification, Vol II, Academic Press, New York. pp. 63-94.
22. Jakoby WB, Ziegler DM 1990. The enzymes of detoxification. J Biol Chem 265: 20715-20718.
23. Jeena KJ, Joy KL, Kuttan R 1999. Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Lett 136: 11-16.
24. Ketterer B, Meyer DJ, Coles B, et al. 1986. Glutathione transferases and carcinogenesis. Basic Life Sci 39: 103-126.
25. King EJ, Wooton IDP, Freeman H 1982. Microanalysis in Medical Biochemistry, 4th edn. Churchill Livingstone, Edinburgh.
26. Kleinsek DA, Ranganathan S, Porter JW 1977. Purification of 3-hydroxy-3-methylglutaryl coenzyme A reductase from rat liver. Proc Natl Acad Sci USA 74: 1431-1435.
27. Klurfeld DM, Kritchevsky D 1981. Serum cholesterol and 7,12-dimethylbenz[α]anthracene induced mammary carcinogenesis. Cancer Lett 14: 273-278.
28. Komiyama K, Iizuka K, Yamaoka M, et al. 1989. Studies on the biological activity of tocotrienols. Chem Pharm Bull 37: 1369-1371.
29. Laughlin LT, Bernat BA, Armstrong RN 1998. Mechanistic imperative for the evolution of a metallo glutathione transferase of the vicinal oxygen chelate superfamily. Chem Biol Interact 111-112: 41-50.
30. Maltese WA 1990. Post-translational modification of proteins by isoprenoids in mammalian cells. FASEB J 4: 3319-3328.
31. Maltzman TH, Tanner MA, Elson CE, et al. 1985. Anticarcinogenic activity of specific orange peel oil monoterpene. Fedn Proc 45: 970.
32. Manaevick B, Alin P, Gluthenbeg C, et al. 1985. Identification of three classes of cytosolic glutathione transferase common to several mammalian species. Proc Natl Acad Sci USA 82: 7202-7206.
33. McIntyre BS, Briski KP, Gapor A, et al. 2000. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Med 224: 292-301.
34. Minhajuddin M, Iqbal J, Beg ZH 1999. Anticholesterol impacts on plasma lipids and apolipoproteins via reduction in HMG-CoA reductase activity and protein mass in normal and hyperlipidemic rat. Proc 11th Indian Society for Atheroscler Res 2: 120-128.
35. Moreno FS, Rossiello MR, Manjeshwar S, et al. 1995. Effect of beta-carotene on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase in rat liver. Cancer Lett 96: 201-208.
36. Moss DW 1987. Diagnostic aspects of alkaline phosphatase and its isoenzymes. Clin Biochem 20: 225-230.
37. Nesaretnam K, Khor HT, Ganeson J, et al. 1992. The effect of vitamin E tocotrienols from palm oil on chemically induced mammary carcinogenesis in female rats. Nutr Res 12: 879-892.
38. Nesaretnam K, Stephen R, Dils R, et al. 1998. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33: 461-469.
39. Nesaretnam K, Dorasamy S, Darbre PD 2000. Tocotrienols inhibit growth of ZR-75-1 breast cancer cells. Int J Food Sci Nutr 51: S95-S103.
40. Ngah WZW, Jarien Z, San MM, et al. 1991. Effects of tocotrienols on hepatocarcinogenesis induced by 2-acetylaminofluorene in rats. Am J Clin Nutr 53: 1076S-1081S.
41. Parker RA, Pearce BC, Clark RW, et al. 1993. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem 268: 11230-11238.
42. Pearce BC, Parker RA, Deason ME, et al. 1992. Hypocholesterolemic activity of synthetic and natural tocotrienols. J Med Chem 35: 3595-3606.
43. Pemble SE, Wardle AF, Taylor JB 1996. Glutathione S-transferase class Kappa: characterization by the cloning of rat mitochondrial GST and identification of a human homologue. Biochem J 319: 749-754.
44. Qureshi AA, Qureshi N, Hasler-Rapacz JO, et al. 1991a. Dietary tocotrienols reduce concentration of plasma cholesterol, apolipoprotein B, thromboxane B2 and platelet factor 4 in pigs with inherited hyperlipidemias. Am J Clin Nutr 53: 1042S-1049S.
45. Qureshi AA, Qureshi N, Wright JJK, et al. 1991b. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am J Clin Nutr 53: 1021S-1026S.
46. Qureshi AA, Mo H, Packer L, et al. 2000. Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumour properties. J Agric Food Chem 48: 3130-3140.
47. Qureshi AA, Sami SA, Salser WA, et al. 2002. Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF(25)) of rice bran in hypercholesterolemic humans. Atherosclerosis 161: 199-207.
48. Raederstorff D, Elste V, Aebischer C, et al. 2002. Effect of either gamma-tocotrienol or a tocotrienol mixture on the plasma lipid profile in hamsters. Ann Nutr Metab 46: 17-23.
49. Rahmat A, Ngah WZ, Shamaan NA, et al. 1993. Long-term administration of tocotrienols and tumor-marker enzyme activities during hepatocarcinogenesis in rats. Nutrition 9: 229-232.
50. Rao KN 1995. The significance of the cholesterol biosynthetic pathway in cell growth and carcinogenesis. Anticancer Res 15: 309-314.
51. Revis NW, Bull R, Laurie D, et al. 1984. The effectiveness of chemical carcinogen to induce atherosclerosis in the white carneau pigeon. Toxicology 32: 215-227.
52. Sato K 1990. Glutathione S-transferases as markers of preneoplasia and neoplasia. Adv Cancer Res 52: 205-255.
53. Schoff SM, Grummer M, Yatvin MB, et al. 1991. Concentration-dependent increase in murine P388 and B16 population doubling time by the acyclic monoterpenes geraniol. Cancer Res 51: 37-42.
54. Schulz S, Buhling F, Ansorge S 1994. Prenylated proteins and lymphocyte proliferation inhibition by d-limonene and related monoterpenes. Eur J Immunol 24: 301-307.
55. Shamaan NA, Ngah WZW, Ibrahim R, et al. 1993. Effect of tocotrienols on the activities of cytosolic glutathione-dependent enzymes in rats treated with 2-acetylaminofluorene. Biochem Pharmacol 45: 1517-1519.
56. Sundram K, Khor HT, Ong ASH, et al. 1989. Effect of dietary palm oils on mammary carcinogenesis in female rats induced by 7,12-dimethylbenz[α]anthracene. Cancer Res 49: 1447-1451.
57. Van Hoof VO, De Broe ME 1994. Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns. Crit Rev Clin Lab Sci 31: 197-293.
58. Van Hoof VO, Deng JT, De Broe ME 1997. How do plasma membranes reach the circulation? Clin Chim Acta 266: 23-31.
59. Wahren B, Harmenberg U 1991. Tumour markers in gastrointestinal cancer. Scand J Clin Lab Invest 206: 21-27.
60. Watkins T, Lenz P, Gapor A, et al. 1993. gamma-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets. Lipids 28: 1113-1118.